These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 14677679

  • 1. Engineering better vaccines for foot-and-mouth disease.
    Mason PW, Chinsangaram J, Moraes MP, Mayr GA, Grubman MJ.
    Dev Biol (Basel); 2003; 114():79-88. PubMed ID: 14677679
    [Abstract] [Full Text] [Related]

  • 2. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 3. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L, Moraes MP, Koster M, Burrage T, Pacheco JM, Segundo FD, Grubman MJ.
    Vaccine; 2008 Oct 23; 26(45):5689-99. PubMed ID: 18762225
    [Abstract] [Full Text] [Related]

  • 4. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.
    Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486
    [Abstract] [Full Text] [Related]

  • 5. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine.
    Pacheco JM, Brum MC, Moraes MP, Golde WT, Grubman MJ.
    Virology; 2005 Jul 05; 337(2):205-9. PubMed ID: 15893355
    [Abstract] [Full Text] [Related]

  • 6. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X, Liu R, Tang H, Jin M, Chen H, Qian P.
    Vaccine; 2008 May 23; 26(22):2714-22. PubMed ID: 18436351
    [Abstract] [Full Text] [Related]

  • 7. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA, Chinsangaram J, Grubman MJ.
    Virology; 1999 Oct 25; 263(2):496-506. PubMed ID: 10544121
    [Abstract] [Full Text] [Related]

  • 8. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.
    de Avila Botton S, Brum MC, Bautista E, Koster M, Weiblen R, Golde WT, Grubman MJ.
    Vaccine; 2006 Apr 24; 24(17):3446-56. PubMed ID: 16522345
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T.
    Clin Vaccine Immunol; 2015 Nov 25; 23(2):125-36. PubMed ID: 26607309
    [Abstract] [Full Text] [Related]

  • 10. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y, Dai J, Li Y, Li C, Qi J, Duan S, Jiang P.
    Vet Immunol Immunopathol; 2008 Aug 15; 124(3-4):274-83. PubMed ID: 18511133
    [Abstract] [Full Text] [Related]

  • 11. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ, Tian CJ, Zhu QS, Zhao MY, Xin AG, Nie WX, Ling SR, Zhu MW, Wu JY, Lan HY, Cao YC, Bi YZ.
    Vaccine; 2008 Mar 10; 26(11):1471-81. PubMed ID: 18289743
    [Abstract] [Full Text] [Related]

  • 12. Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues.
    Montiel N, Smoliga G, Arzt J.
    Vaccine; 2012 Feb 21; 30(9):1690-701. PubMed ID: 22227230
    [Abstract] [Full Text] [Related]

  • 13. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA, McIlhaney M, Miller T, Christianson K, Keene A, Lohnas G, Purcell C, Neilan J, Schutta C, Barrera J, Burrage T, Brough DE, Butman BT.
    Dev Biol (Basel); 2012 Feb 21; 134():123-33. PubMed ID: 22888605
    [Abstract] [Full Text] [Related]

  • 14. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P, Li XM, Jin ML, Peng GQ, Chen HC.
    Vaccine; 2004 Jun 02; 22(17-18):2129-36. PubMed ID: 15149769
    [Abstract] [Full Text] [Related]

  • 15. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M, Jin N, Zhang H, Jin M, Lu H, Ma M, Li C, Yin G, Wang R, Liu Q.
    J Virol Methods; 2006 Sep 02; 136(1-2):230-7. PubMed ID: 16780963
    [Abstract] [Full Text] [Related]

  • 16. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
    Moraes MP, Mayr GA, Mason PW, Grubman MJ.
    Vaccine; 2002 Feb 22; 20(11-12):1631-9. PubMed ID: 11858872
    [Abstract] [Full Text] [Related]

  • 17. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, Pacheco JM, LaRocco M, Palarea-Albaladejo J, Brake D, Rieder E, Arzt J, Barlow JW, Golde WT.
    Vaccine; 2019 Sep 30; 37(42):6221-6231. PubMed ID: 31493951
    [Abstract] [Full Text] [Related]

  • 18. Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.
    Yao Q, Qian P, Huang Q, Cao Y, Chen H.
    J Virol Methods; 2008 Jan 30; 147(1):143-50. PubMed ID: 17963851
    [Abstract] [Full Text] [Related]

  • 19. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.
    Chen W, Liu M, Jiao Y, Yan W, Wei X, Chen J, Fei L, Liu Y, Zuo X, Yang F, Lu Y, Zheng Z.
    J Virol; 2006 Apr 30; 80(7):3559-66. PubMed ID: 16537624
    [Abstract] [Full Text] [Related]

  • 20. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G, Zhao X, Yan W, Wang W, Zuo X, Huang K, Liu Y, Chen J, Wang J, Cong W, Liu M, Gao H, Chen J, Lu Y, Zheng Z.
    Vaccine; 2007 Jul 09; 25(28):5199-208. PubMed ID: 17555848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.